Medication info
Unisium Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Unisium Tablet 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28T (14T/PTP X 2)
Approval status
Active

MFDS item code 201507785 · Approved 2015.11.20 · Insurance code 665506790

Summary

Main use
Treatment of acid-related disorders, ulcers, Helicobacter pylori eradication and prevention of rebleeding, and NSAID-induced gastrointestinal disorders
Who uses it
Adults · Children
Adult dosage
Once daily, 40 mg per dose If esophagitis has not healed or symptoms persist, continue taking it for 4 more weeks. Once daily, 20 mg per dose Once daily, 20 mg per dose. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Once symptoms have subsided, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to NSAID treatment, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Once daily, 20 mg per dose. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Once daily, 20 mg per dose. The treatment period is 4∼8 weeks. Once daily, 20 mg per dose. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for 4 more weeks. Adolescents 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents 12 years and older: Once symptoms have subsided, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administering this medicine to children under 12 years.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders, ulcers, Helicobacter pylori eradication and prevention of rebleeding, and NSAID-induced gastrointestinal disorders

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, especially erosive esophagitis, and for long-term maintenance therapy to prevent recurrence in esophagitis patients. It is also effective in relieving symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers in patients with Helicobacter pylori infection. Additionally, it helps in the treatment and prevention of gastric and duodenal ulcers associated with upper gastrointestinal symptoms due to non-steroidal anti-inflammatory drug use. The medication is also used to treat Zollinger-Ellison syndrome and as a maintenance therapy to prevent rebleeding due to gastric or duodenal ulcers. Overall, it is an effective medication for the treatment and prevention of various diseases of the stomach and esophagus.

Dosage and Administration

Adult dosage

Once daily, 40 mg per dose If esophagitis has not healed or symptoms persist, continue taking it for 4 more weeks. Once daily, 20 mg per dose Once daily, 20 mg per dose. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Once symptoms have subsided, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to NSAID treatment, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Once daily, 20 mg per dose. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Once daily, 20 mg per dose. The treatment period is 4∼8 weeks. Once daily, 20 mg per dose. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. Administer 40 mg once daily for 4 weeks after intravenous treatment to induce prevention of rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for 4 more weeks. Adolescents 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents 12 years and older: Once symptoms have subsided, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administering this medicine to children under 12 years.

Precautions

This medication should not be administered to patients who are hypersensitive to certain ingredients or benzimidazole derivatives. Patients with hypersensitivity to penicillin or macrolide antibiotics should also be cautious. Special caution should be taken during combination therapy for eradication of Helicobacter pylori. Additionally, this medication is not to be administered to patients taking certain heart-related medications or antivirals, nursing women, or those with a history of myocardial infarction. Uncommon adverse reactions may occur in various systems including blood, immune, metabolic, psychiatric, neurological, gastrointestinal, liver, skin, etc., so patients should consult a physician if any abnormal symptoms arise. Prolonged use may lead to electrolyte imbalances such as hypomagnesemia, necessitating regular testing. This medication can suppress gastric acid secretion, increasing the risk of bacterial overgrowth in the stomach, so if diarrhea persists, it should be reported to healthcare professionals. Due to numerous drug interactions, patients must consult a physician or pharmacist when taking with other medications, especially antivirals, anticoagulants, and certain antibiotics. Its safety during pregnancy has not been fully established, so it should only be used cautiously when necessary, and it should not be used during breastfeeding. In case of overdose, as there is no specific antidote, patients should seek immediate treatment from medical institutions. It is safe to store out of reach of children and not transfer into other containers.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Reiter's syndrome, acute generalized pustular psoriasis, drug reactions with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, tachycardia, flushing, hypertension, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased blood gastrin levels, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervicofacial lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal pruritus, erythematous rash, papular rash, otitis media, olfactory disturbances, loss of taste, taste dysfunction, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28T (14T/PTP X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.